Overview

Total Neoadjuvant Therapy in Rectal Cancer Treatment

Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, controlled, parallel study to determine the efficiency and safety of total neoadjuvant therapy in rectal cancer treatment.
Phase:
Phase 4
Details
Lead Sponsor:
State Scientific Centre of Coloproctology, Russian Federation